The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities.
Novel therapies for severe asthma in children and adults / Delimpoura, V; Bostantzoglou, C; Liu, N; Nenna, R. - In: BREATHE. - ISSN 1810-6838. - 14:1(2018), pp. 59-62. [10.1183/20734735.018917]
Novel therapies for severe asthma in children and adults
Nenna R
2018
Abstract
The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
